company background image
IMP logo

Imexpharm HOSE:IMP Stock Report

Last Price

₫74.40k

Market Cap

₫5.2t

7D

3.9%

1Y

31.1%

Updated

20 Jun, 2024

Data

Company Financials +

IMP Stock Overview

Manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally.

IMP fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance5/6
Financial Health4/6
Dividends0/6

Imexpharm Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Imexpharm
Historical stock prices
Current Share Price₫74,400.00
52 Week High₫74,400.00
52 Week Low₫52,100.00
Beta0.70
11 Month Change11.71%
3 Month Change7.36%
1 Year Change31.07%
33 Year Change-2.96%
5 Year Change112.24%
Change since IPO60.59%

Recent News & Updates

Recent updates

Shareholder Returns

IMPVN PharmaceuticalsVN Market
7D3.9%0.9%-1.8%
1Y31.1%9.2%12.6%

Return vs Industry: IMP exceeded the VN Pharmaceuticals industry which returned 9.2% over the past year.

Return vs Market: IMP exceeded the VN Market which returned 12.6% over the past year.

Price Volatility

Is IMP's price volatile compared to industry and market?
IMP volatility
IMP Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement4.8%
10% most volatile stocks in VN Market7.5%
10% least volatile stocks in VN Market2.8%

Stable Share Price: IMP has not had significant price volatility in the past 3 months.

Volatility Over Time: IMP's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19771,411Dao Tranwww.imexpharm.com

Imexpharm Corporation manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally. The company’s products include oral and injectable antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-histamines, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals. It is also involved in the import and export of medical equipment and supplies, chemicals, materials for medicine manufacturing and packaging, and chemicals used for sterilization or disinfection in humans.

Imexpharm Corporation Fundamentals Summary

How do Imexpharm's earnings and revenue compare to its market cap?
IMP fundamental statistics
Market cap₫5.21t
Earnings (TTM)₫241.10b
Revenue (TTM)₫2.01t

21.6x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMP income statement (TTM)
Revenue₫2.01t
Cost of Revenue₫1.06t
Gross Profit₫941.69b
Other Expenses₫700.59b
Earnings₫241.10b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)3.44k
Gross Margin46.95%
Net Profit Margin12.02%
Debt/Equity Ratio5.5%

How did IMP perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

27%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.